{
  "id": 16938960,
  "title": "Biotechs buck a sluggish IPO market, but investors should tread warily",
  "url": "https://urgent.news/2026/10/28/biotechs-buck-a-sluggish-ipo-market-but-investors-should-tread-warily",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-28T17:47:45.000Z",
  "source": {
    "name": "CNBC",
    "slug": "cnbc",
    "url": "https://www.cnbc.com/2026/10/28/biotech-ipo-market-investor-risks.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "While a number of IPOs have been pulled or delayed in 2026, the biotech sector has bucked the trend, with 26 companies debuting in U.S. markets.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}